Rare diseases
Investigational molecules
Locations
Back to Czechia544 clinical trials in Novy Jicin, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study on the Effectiveness and Safety of NT 201 (Botulinum Toxin) for Treating Lower Limb Spasticity in Adults After Stroke or Traumatic Brain Injury
CzechiaStudy on TIN816 for Preventing Acute Kidney Injury in Adults Undergoing Cardiac Surgery
CzechiaStudy on Frexalimab for Patients with Relapsing Multiple Sclerosis
CzechiaStudy of amlitelimab injection compared to placebo for adults with severe alopecia areata (hair loss)
CzechiaStudy of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer
CzechiaStudy Comparing Isatuximab with Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant
CzechiaStudy on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment
CzechiaStudy on Stopping Nilotinib, Imatinib, and Dasatinib in Patients with Chronic Myeloid Leukemia in Deep Remission
CzechiaStudy of Disulfiram and Copper for Patients with Metastatic Breast Cancer
CzechiaStudy on Long-Term Safety and Effects of Pegcetacoplan for Patients with Geographic Atrophy from Age-Related Macular Degeneration
CzechiaStudy on the Effects of Isatuximab with Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
CzechiaStudy of belantamab mafodotin, bortezomib and dexamethasone combination in adults with relapsed or refractory multiple myeloma who received at least one prior therapy
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on various types of cancer, including non-small cell lung cancer, breast cancer, and prostate cancer. Studies are evaluating novel combination therapies and treatment approaches for advanced stages of disease.
Emphasis on targeted therapies and immunotherapy combinations for improved patient outcomes.
Comprehensive research into skin conditions, particularly plaque psoriasis and atopic dermatitis. Trials are investigating long-term safety and efficacy of new therapeutic agents.
Focus on developing sustainable treatment options for chronic skin conditions.
Diverse research portfolio including studies in nephrology, gastroenterology, and rheumatology. Trials examining innovative treatments for conditions such as IgA nephropathy and short bowel syndrome.
Investigating targeted therapies for complex medical conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
